000			01607cam a22004457a 4500
001			13175936
003			IQ-KoUCL
005			20160614085037.0
008			030425s2003 enkaf b 001 0 eng
010			_a 2003535344
015			_aGBA2-W6529
016	7		_a101167536 _2DNLM
020			_a0198508964 (hbk. : alk. paper)
035			_a(OCoLC)ocm50055138
040			_aNLM _cNLM _dUKM _dDLC
042			_alccopycat
050	0	0	_aRC271.I45 _bT37 2003
060	0	0	_a2003 C-022
060	1	0	_aQZ 266 _bT185 2003
082	0	4	_a616.99406 _221
245	0	0	_aTargeted therapy for cancer / _cedited by Konstantinos N. Syrigos and Kevin J. Harrington.
260			_aOxford ; _aNew York : _bOxford University Press, _c2003.
300			_axviii, 343 p., [4] p. of plates : _bill. (some col.) ; _c26 cm.
504			_aIncludes bibliographical references and index.
650		0	_aCancer _xImmunotherapy.
650		0	_aCancer _xRadioimmunotherapy.
650		0	_aCancer _xGene therapy.
650		0	_aDrug targeting.
650	1	2	_aNeoplasms _xtherapy.
650	2	2	_aAntibodies, Monoclonal.
650	2	2	_aGene Therapy.
650	2	2	_aImmunotherapy.
700	1		_aSyrigos, Konstantinos N.
700	1		_aHarrington, Kevin J., _d1958-
856	4	2	_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0616/2003535344-d.html
856	4	1	_3Table of contents only _uhttp://www.loc.gov/catdir/enhancements/fy0616/2003535344-t.html
906			_a7 _bcbc _ccopycat _d2 _encip _f20 _gy-gencatlg
942			_2ddc _cBK
999			_c137732 _d137732